Achieve Life Sciences, Inc.
Support and Resistance Levels
Past performance
News About ACHV
All events for ACHV
All deals for ACHV
Financial Ratios
Financial Statements
ACHV vs Sector & Peers
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada. Website achievelifesciences.com
Headquarters Bothell, WA, US